Effect of verocytotoxins (Shiga-like toxins) on human neutrophils in vitro

Pediatric Nephrology

Volumn 20, Issue 9, 2005, Pages 1237-1244

  Holle, Julie U ^a   Williams, Julie M ^a   Harper, Lorraine ^a   Savage, Caroline O S ^a   Taylor, C Mark ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Chemotaxis; Elastase; Neutrophils; Priming; Protein synthesis inhibition; Superoxide; Verocytotoxin (Shiga like toxin)

Indexed keywords

CELL ADHESION MOLECULE; ELASTASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PHORBOL MYRISTATE; SUPEROXIDE; VEROTOXIN; VEROTOXIN 1; VEROTOXIN 2;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; CERCOPITHECUS AETHIOPS; CHEMOTAXIS, LEUKOCYTE; HUMANS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PANCREATIC ELASTASE; SHIGA TOXINS; SHIGA-LIKE TOXIN I; SUPEROXIDES; VERO CELLS;

EID: 24044525259     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-1945-2     Document Type: Article

References (36)

1. O'Brien AD, Holmes RK (1987) Shiga and Shiga-like toxins. Microbiol Rev 51:206-220
2. Stein PE, Boodhoo A, Tyrrell GJ, et al (1992) Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature 355:748-750 10.1038/355748a0
3. Lingwood CA. (1994) Verotoxin-binding in human renal sections. Nephron 66:21-28 1:STN:280:ByuC2M%2FnvFE%3D
4. Ergonul Z, Clayton F, Fogo AB, Kohan DE (2003) Shigatoxin-1 binding and receptor expression in human kidneys do not change with age. Pediatr Nephrol 18:246-0253 12644917
5. Bitzan M, Richardson S, Huang C, et al (1994) Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro. Infect Immun 62:3337-3347 1:CAS:528:DyaK2cXlslOisrs%3D
6. van Setten PA, Monnens LAH, Verstraten RG, et al.(1996) Effects of verotoxin-1 on non-adherent human monocytes: Binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174-183
7. Cooling LL, Walker KE, Gille T, et al (1998) Shiga toxins binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid. Infect Immun 66:4355-4366 1:CAS:528:DyaK1cXlslCrtLw%3D
8. Lingwood CA (1996) Role of verotoxin receptors in pathogenesis. Trends Microbiol 4:147-153
9. te Loo M, Monnens LA, van der Velden TJ, et al (2000) Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95:396-2402 10828021
10. Tesh VL, Samuel JE, Perera LP, et al (1994) Evalution of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 164:344-352
11. Louise CB, Obrig TG (1992) Shiga toxin-associated hemolytic uremic syndrome: Combined cytotoxic effects of Shiga-toxin, interleukin-1β and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 59:1536-1543
12. van de Kar NC, Kooistra T, Vermeer M, et al (1992) Tumor necrosis factor alpha and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: Implications for the pathogenesis of the haemolytic uremic syndrome. Blood 80:275-2764 1333300
13. Thorpe CM, Hurley BP, Lincicome LL, et al (1999) Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect Immun 67:5985-5993 1:CAS:528:DyaK1MXntV2rurs%3D
14. Morigi M, Micheletti G, Figliuzzi M, et al (1995) Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. Blood 86:4553-4558 1:CAS:528:DyaK2MXpvFCjs74%3D
15. Zoja C, Angioletti S, Donadelli R, et al (2002) Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kB dependent upregulation of IL-8 and MCP-1. Kidney Int 62:846-856 10.1046/ j.1523-1755.2002.00503.x
16. Ishii H, Takada K, Higuchi T, et al (2000) Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kB/Rel and AP-1. Thromb Haemost 84:712-721 1:CAS:528:DC%2BD3cXnslWqs7c%3D
17. Chandler WL, Jelacic S, Boster DR, et al (2002) Prothrombotic coagulation abnormalities preceding the haemolytic-uremic syndrome. N Engl J Med 346:23-32 10.1056/NEJMoa011033
18. King AJ, Sundaram S, Cendoroglo M, et al (1999) Shiga toxin induces superoxide production in polymorphonuclear cells with subsequent impairment of phagocytosis and responsiveness to phorbol esters. J Infect Dis 179:503-507 10.1086/314579
19. Aoki Y, Takeda T (2002) Effect of Shiga toxins on granulocyte function. Microb Pathog 32: 279-285
20. Bajaj MS, Kew RR, Webster RO, et al (1992) Priming of human neutrophil functions by tumor necrosis factor - enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe. Inflammation 16: 241-50 10.1007/BF00918813
21. Sengelov H, Follin P, Kjeldsen L, et al (1995) Mobilization of granules and secretory granules during in vivo exudation of human neutrophils. J Immunol 154:4157-4165 1:STN:280:ByqB387pt1A%3D
22. O'Flaherty JT, Rossi AG, Redman JF, et al (1991) Tumor necrosis factor- regulates expression of receptors for formyl-methionyl.leucyl-phenylalanine, leukotriene B4, and platelet-activating factor. Dissociation from priming in human polymorphonuclear neutrophils. J Immunol 147:3842-3847 1658151
23. Zimmerli W, Seligmann B, Gallin JI (1986) Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases component C3b. J Clin Invest 77:925-933
24. Condliffe AM, Chilvers RR, Haslett C, et al (1996) Priming differentially regulates neutrophil adhesion molecule expression/ function. Immunology 89:105-111
25. Kuhns DB, Priel DAL, Gallin JL (1995) Loss of l-Selectin (CD62L) on human neutrophils following exudation in vivo. Cell Immunol 164:306-310 10.1006/cimm.1995.1174
26. Liu J, He The Y, Zhang Z, et al (2002) Prolongation of functional life-span of neutrophils by recombinant verotoxin 2. Chin Med J 115:900-903 1:CAS:528:DC%2BD38XlvVWjtb0%3D
27. Liu J, Akahoshi T, Sasahana T, et al (1999) Inhibition of neutrophil apoptosis by verotoxin 2 derived from Escherichia coli O157:H7. Infect Immun 67:6203-6205 1:CAS:528:DyaK1MXntV2qs7k%3D
28. Cutler JE, Munoz JJ (1974) A simple method for studies on chemotaxis. Proc Soc Exp Biol Med 147(2):471-474
29. Nelson RD, Quie PG, Simmons RL (1975) Chemotaxis under agarose: A new simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leucocytes and monocytes. J Immunol 115(6):1650-1656
30. Pavia AT, Nichols CR, Green DP, et al. (1990) Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observations. J Pediatr 116:544-551 1:STN:280:By%2BB3cvhsFE%3D
31. Walters MD, Matthei IU, and Kay R, et al (1989) The polymorphonuclear leucocyte count in childhood haemolytic uremic syndrome. Pediatr Nephrol 3:130-134 10.1007/BF00852893
32. Fitzpatrick MM, Shah V, Filler G, et al (1992) Neutrophil activation in the haemolytic uremic syndrome: Free and complexed elastase in plasma. Pediatr Nephrol 6(1):50-53
33. Ishikawa N, Kamitsuji H, Murakami T, et al (2000) Plasma levels of granulocyte elastase-α1-proteinase inhibitor complex in children with haemolytic uremic syndrome caused by verotoxin-producing Escherichia coli. Pediatr Int 42:637-641 10.1046/ j.1442-200x.2000.01309.x
34. Inward CD, Howie AJ, and Fitzpatrick MM, et al (1997) Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. British Association for Paediatric Nephrology. Pediatr Nephrol 11(5):556-559 10.1007/s004670050337
35. Fitzpatrick MM, Shah V, Trompeter RS, et al (1992) Interleukin-8 and polymorphonuclear leucocyte activation in haemolytic uremic syndrome of childhood. Kidney Int 42(4):952-962
36. Kettritz R, Falk RJ, Jennette JC, Gaido ML (1997) Neutrophhil superoxide release is required for spontaneous and FMLP-mediated but not TNF alpha-mediated apoptosis. J Am Soc Nephrol 8(7):1091-1100 1:CAS:528:DyaK1cXhtVWqt7w%3D